$EXEL
EXELIXIS, INC.

2019 Q4 Form 10-Q Financial Statement

#000093976719000190 Filed on October 30, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $240.3M $271.7M $228.6M
YoY Change 5.12% 20.54% 90.39%
Cost Of Revenue $10.50M $7.537M $7.400M
YoY Change 41.89% 2.4% 76.19%
Gross Profit $229.8M $184.2M $168.9M
YoY Change 36.08% 18.41% 84.52%
Gross Profit Margin 95.63% 67.81% 73.87%
Selling, General & Admin $58.00M $51.27M $52.40M
YoY Change 10.69% 6.54% 13.42%
% of Gross Profit 25.24% 27.83% 31.03%
Research & Development $94.40M $97.30M $57.30M
YoY Change 64.75% 117.46% 77.95%
% of Gross Profit 41.08% 52.81% 33.93%
Depreciation & Amortization $2.200M $2.100M $2.000M
YoY Change 10.0% 23.53% 400.0%
% of Gross Profit 0.96% 1.14% 1.18%
Operating Expenses $152.5M $156.1M $109.6M
YoY Change 39.14% 55.75% 39.8%
Operating Profit $77.30M $115.6M $111.6M
YoY Change -30.74% -7.65% 198.15%
Interest Expense $7.700M $7.200M $4.700M
YoY Change 63.83% 719900.0%
% of Operating Profit 9.96% 6.23% 4.21%
Other Income/Expense, Net $0.00 $7.051M $0.00
YoY Change 86.63% -100.0%
Pretax Income $85.00M $122.7M $116.4M
YoY Change -26.98% -4.88% 199.23%
Income Tax $16.30M $25.21M -$243.7M
% Of Pretax Income 19.18% 20.55% -209.36%
Net Earnings $68.70M $97.45M $360.1M
YoY Change -80.92% -23.04% 835.56%
Net Earnings / Revenue 28.59% 35.87% 157.52%
Basic Earnings Per Share $0.32 $1.20
Diluted Earnings Per Share $218.2K $0.31 $1.15
COMMON SHARES
Basic Shares Outstanding 303.8M shares 303.3M shares 299.0M shares
Diluted Shares Outstanding 315.5M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $852.2M $760.7M $693.3M
YoY Change 22.92% 19.87% 78.78%
Cash & Equivalents $266.5M $242.3M $314.8M
Short-Term Investments $585.7M $518.4M $378.6M
Other Short-Term Assets $27.00M $14.50M $15.00M
YoY Change 80.0% 13.28% 61.29%
Inventory $12.90M $13.37M $9.838M
Prepaid Expenses
Receivables $119.1M $169.8M $162.8M
Other Receivables $0.00 $13.80M $16.06M
Total Short-Term Assets $1.011B $972.1M $897.0M
YoY Change 12.73% 23.53% 85.0%
LONG-TERM ASSETS
Property, Plant & Equipment $48.90M $49.47M $50.90M
YoY Change -3.92% -3.09% 353.91%
Goodwill $63.68M $63.68M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $536.4M $486.8M $157.2M
YoY Change 241.22% 326.64% 144.48%
Other Assets $225.5M $7.268M $8.291M
YoY Change 2619.82% 387.13% -31.43%
Total Long-Term Assets $874.5M $812.8M $525.3M
YoY Change 66.49% 242.35% 208.22%
TOTAL ASSETS
Total Short-Term Assets $1.011B $972.1M $897.0M
Total Long-Term Assets $874.5M $812.8M $525.3M
Total Assets $1.886B $1.785B $1.422B
YoY Change 32.58% 74.24% 117.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.60M $8.352M $10.90M
YoY Change 6.41% -3.77% 13.85%
Accrued Expenses $90.70M $72.70M $60.50M
YoY Change 49.92% 3.12% -8.33%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $0.00
YoY Change
Total Short-Term Liabilities $142.7M $141.1M $105.5M
YoY Change 35.3% 55.18% -8.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% -99.31%
Other Long-Term Liabilities $57.00M $975.0K $1.286M
YoY Change 4332.35% -62.6% -24.57%
Total Long-Term Liabilities $57.00M $975.0K $1.286M
YoY Change 4332.35% -62.6% -24.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.7M $141.1M $105.5M
Total Long-Term Liabilities $57.00M $975.0K $1.286M
Total Liabilities $199.7M $181.1M $134.8M
YoY Change 48.11% 67.11% -63.59%
SHAREHOLDERS EQUITY
Retained Earnings -$628.1M -$880.4M
YoY Change -49.37% -43.94%
Common Stock $304.0K $300.0K
YoY Change 1.67% 1.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.686B $1.604B $1.287B
YoY Change
Total Liabilities & Shareholders Equity $1.886B $1.785B $1.422B
YoY Change 32.58% 74.24% 117.05%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income $68.70M $97.45M $360.1M
YoY Change -80.92% -23.04% 835.56%
Depreciation, Depletion And Amortization $2.200M $2.100M $2.000M
YoY Change 10.0% 23.53% 400.0%
Cash From Operating Activities $158.1M $75.60M $104.6M
YoY Change 51.15% -54.13% 96.25%
INVESTING ACTIVITIES
Capital Expenditures -$7.200M -$2.100M -$2.900M
YoY Change 148.28% -86.18% -83.62%
Acquisitions
YoY Change
Other Investing Activities -$122.9M -$204.4M -$140.0M
YoY Change -12.21% 325.83% 19900.0%
Cash From Investing Activities -$130.2M -$206.4M -$142.8M
YoY Change -8.82% 226.07% 680.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000M 3.300M -1.100M
YoY Change 172.73% -8.33% 57.14%
NET CHANGE
Cash From Operating Activities 158.1M 75.60M 104.6M
Cash From Investing Activities -130.2M -206.4M -142.8M
Cash From Financing Activities -3.000M 3.300M -1.100M
Net Change In Cash 24.90M -127.5M -39.30M
YoY Change -163.36% -221.31% -214.58%
FREE CASH FLOW
Cash From Operating Activities $158.1M $75.60M $104.6M
Capital Expenditures -$7.200M -$2.100M -$2.900M
Free Cash Flow $165.3M $77.70M $107.5M
YoY Change 53.77% -56.83% 51.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-03
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000939767
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
299876080 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303776032 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
299876080 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303776032 shares
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 USD
CY2018Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
129000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
936000 USD
CY2018Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2019Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-27
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30235
dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3257395
dei Entity Address Address Line1
EntityAddressAddressLine1
1851 Harbor Bay Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Alameda,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94502
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
837-7000
dei Security12b Title
Security12bTitle
Common Stock $.001 Par Value per Share
dei Trading Symbol
TradingSymbol
EXEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
303846306 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242317000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314775000 USD
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
518350000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
378559000 USD
CY2019Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
169788000 USD
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
162771000 USD
CY2019Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
13801000 USD
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16056000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
13366000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
9838000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14490000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15017000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
972112000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
897016000 USD
CY2019Q3 us-gaap Long Term Investments
LongTermInvestments
486763000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
157187000 USD
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1000000 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1100000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49467000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50897000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17735000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5867000 USD
CY2019Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
186836000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
244111000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
63684000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7268000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2424000 USD
CY2019Q3 us-gaap Assets
Assets
1784865000 USD
CY2018Q4 us-gaap Assets
Assets
1422286000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8352000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10901000 USD
CY2019Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
31713000 USD
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
32142000 USD
CY2019Q3 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
30330000 USD
CY2018Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
18231000 USD
CY2019Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
16782000 USD
CY2018Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
14954000 USD
CY2019Q3 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
7973000 USD
CY2018Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
7419000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45919000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21825000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
141069000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
105472000 USD
CY2019Q3 exel Operating And Finance Leases Liability Long Term
OperatingAndFinanceLeasesLiabilityLongTerm
23705000 USD
CY2018Q4 exel Operating And Finance Leases Liability Long Term
OperatingAndFinanceLeasesLiabilityLongTerm
12178000 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15399000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15897000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
975000 USD
us-gaap Operating Expenses
OperatingExpenses
435311000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1286000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
181148000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
134833000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
304000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
300000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2228839000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2168217000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2668000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-701000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628094000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-880363000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1603717000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1287453000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1784865000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1422286000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271703000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225397000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727465000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
625224000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7537000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7360000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22577000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18996000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97295000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44741000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
242516000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
124986000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51265000 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48120000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
170218000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153989000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
156097000 USD
us-gaap Operating Expenses
OperatingExpenses
297971000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
115606000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
125176000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
100221000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
292154000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
327253000 USD
CY2019Q3 us-gaap Interest Income Other
InterestIncomeOther
7191000 USD
CY2018Q3 us-gaap Interest Income Other
InterestIncomeOther
3507000 USD
us-gaap Interest Income Other
InterestIncomeOther
20253000 USD
us-gaap Interest Income Other
InterestIncomeOther
8099000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-140000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
271000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
688000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
368000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7051000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3778000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20941000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8467000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
122657000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
128954000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
313095000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
335720000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25205000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2324000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60826000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5739000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
126630000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Net Income Loss
NetIncomeLoss
329981000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303268000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301999000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315453000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
312346000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
313200000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
126630000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Net Income Loss
NetIncomeLoss
329981000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
461000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
218000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3369000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-166000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
461000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
218000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3369000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-166000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
97913000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
126848000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
255638000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
329815000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1488632000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
461000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4033000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13139000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1603717000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
775202000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
126630000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
218000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4174000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9742000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
915966000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1287453000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3369000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19879000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40747000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1603717000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284961000 USD
us-gaap Net Income Loss
NetIncomeLoss
329981000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-166000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14121000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28330000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
915966000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Net Income Loss
NetIncomeLoss
329981000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6088000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2876000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
40747000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
28330000 USD
us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
4079000 USD
us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
3232000 USD
exel Right Of Use Asset Amortization
RightOfUseAssetAmortization
-6367000 USD
exel Right Of Use Asset Amortization
RightOfUseAssetAmortization
2732000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-56339000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
730000 USD
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
209000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3970000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1423000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7017000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12707000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2469000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2938000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3528000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3776000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2640000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
32673000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-527000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3529000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6294000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
542000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2708000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1248000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-429000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6210000 USD
exel Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
12099000 USD
exel Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
-891000 USD
exel Increase Decrease In Rebates And Fees Payable
IncreaseDecreaseInRebatesAndFeesPayable
1828000 USD
exel Increase Decrease In Rebates And Fees Payable
IncreaseDecreaseInRebatesAndFeesPayable
4124000 USD
exel Increase Decrease In Accrued Collaboration Liability
IncreaseDecreaseInAccruedCollaborationLiability
554000 USD
exel Increase Decrease In Accrued Collaboration Liability
IncreaseDecreaseInAccruedCollaborationLiability
-577000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3592000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1548000 USD
exel Increase Decrease In Lease Liability Noncurrent
IncreaseDecreaseInLeaseLiabilityNoncurrent
6087000 USD
exel Increase Decrease In Lease Liability Noncurrent
IncreaseDecreaseInLeaseLiabilityNoncurrent
-974000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15940000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3321000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
368935000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
311129000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5575000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30403000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
308000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
887698000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
368304000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
422419000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
231204000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
13078000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11935000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
730000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
209000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-457046000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-155051000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14811000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10390000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4145000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3650000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3369000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3205000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
34000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15553000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10835000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72558000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
166913000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315875000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188314000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243317000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355227000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
12944000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
17180000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
159000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1281000 USD
exel Liabilities Expenditures Incurred But Not Yet Paid To Related Party Transactions
LiabilitiesExpendituresIncurredButNotYetPaidToRelatedPartyTransactions
8961000 USD
exel Liabilities Expenditures Incurred But Not Yet Paid To Related Party Transactions
LiabilitiesExpendituresIncurredButNotYetPaidToRelatedPartyTransactions
0 USD
exel Numberof Productsin Commercial Market
NumberofProductsinCommercialMarket
4 product
us-gaap Fiscal Period
FiscalPeriod
<div style="line-height:120%;padding-bottom:0px;padding-top:12px;text-align:left;padding-left:0px;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">We have adopted a 52- or 53-week fiscal year policy that generally ends on the Friday closest to December 31</span><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup></span><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">. Fiscal year 2019, which is a 53-week fiscal year, will end on January 3, 2020 and fiscal year 2018, which was a 52-week fiscal year, ended on December 28, 2018. For convenience, references in this report as of and for the fiscal periods ended September 27, 2019, June 28, 2019, September 28, 2018 and June 29, 2018, and as of and for the fiscal years ending January 3, 2020, and ended December 28, 2018 and December 29, 2017, are indicated as being as of and for the periods ended September 30, 2019, June 30, 2019, September 30, 2018 and June 30, 2018 and the years ending December 31, 2019, and ended December 31, 2018 and December 31, 2017, respectively. Similarly, references in this report to the first day of the fiscal year ended January 3, 2020 are indicated as being as of January 1, 2019 and the first day of the fiscal quarter ended September 27, 2019 are indicated as being as of July 1, 2019.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:12px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:12px;text-align:left;padding-left:0px;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">The preparation of the accompanying Condensed Consolidated Financial Statements conforms to accounting principles generally accepted in the U.S., which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to: those related to revenue recognition, including determining the nature and timing of satisfaction of performance obligations, and determining the standalone selling price of performance obligations, and variable consideration such as rebates, chargebacks, sales returns, sales allowances, and milestone payments included in collaboration arrangements; the amounts of revenues and expenses under our profit and loss sharing agreement; the recoverability of inventory; the amounts of operating lease right-of-use assets and lease liabilities; the amounts of deferred tax assets and liabilities including the related valuation allowance; the accrual for certain liabilities including accrued clinical trial liabilities; and valuations of equity awards used to determine stock-based compensation, including certain awards with vesting subject to market or performance conditions. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</span></div>
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271703000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225397000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727465000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
625224000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271703000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225397000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727465000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
625224000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271703000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225397000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727465000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
625224000 USD
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
17276000 USD
exel Valuation Allowances And Reserves Additions For Sales In Current Period
ValuationAllowancesAndReservesAdditionsForSalesInCurrentPeriod
139381000 USD
exel Valuation Allowances And Reserves Additions For Sales In Prior Period
ValuationAllowancesAndReservesAdditionsForSalesInPriorPeriod
-321000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
136910000 USD
CY2019Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
19426000 USD
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15400000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15900000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6100000 USD
CY2019Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
67700000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
129000000.0 USD
CY2018Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
48200000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
151800000 USD
CY2019Q3 exel Collaboration Agreement Additional Option Payments
CollaborationAgreementAdditionalOptionPayments
7500000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242317000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314775000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353623000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
183164000 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
504000 USD
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
504000 USD
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1000000 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1100000 USD
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1100000 USD
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
4646000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243317000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315875000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355227000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188314000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1214736000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3692000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1218337000 USD
CY2019Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1244826000 USD
CY2019Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3695000 USD
CY2019Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91000 USD
CY2019Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1248430000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
828843000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
182000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
883000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
828142000 USD
CY2018Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
852322000 USD
CY2018Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
182000 USD
CY2018Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
883000 USD
CY2018Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
851621000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
119808000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
90000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4398000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
124206000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
91000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
271358000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
623000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
48809000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
260000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
320167000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
883000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
43 investment
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
199 investment
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
743768000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
674455000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
474569000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
153687000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1218337000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
828142000 USD
CY2018Q4 exel Ownership Interest By Minority Shareholder
OwnershipInterestByMinorityShareholder
0.10
CY2019Q3 exel Related Party Transactions Cash And Investments Managed By Minority Owner
RelatedPartyTransactionsCashAndInvestmentsManagedByMinorityOwner
470800000 USD
CY2018Q4 exel Related Party Transactions Cash And Investments Managed By Minority Owner
RelatedPartyTransactionsCashAndInvestmentsManagedByMinorityOwner
298500000 USD
CY2019Q3 exel Related Party Transactions Cash And Investments Managed By Minority Owner Invested In Money Market Fund
RelatedPartyTransactionsCashAndInvestmentsManagedByMinorityOwnerInvestedInMoneyMarketFund
1900000 USD
CY2018Q4 exel Related Party Transactions Cash And Investments Managed By Minority Owner Invested In Money Market Fund
RelatedPartyTransactionsCashAndInvestmentsManagedByMinorityOwnerInvestedInMoneyMarketFund
3000000.0 USD
CY2019Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
9000000.0 USD
exel Related Party Transactions Advisory Fees Incurred
RelatedPartyTransactionsAdvisoryFeesIncurred
200000 USD
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1906000 USD
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1922000 USD
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
11035000 USD
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6170000 USD
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7311000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3836000 USD
CY2019Q3 us-gaap Inventory Gross
InventoryGross
20252000 USD
CY2018Q4 us-gaap Inventory Gross
InventoryGross
11928000 USD
CY2019Q3 us-gaap Inventory Gross
InventoryGross
20252000 USD
CY2018Q4 us-gaap Inventory Gross
InventoryGross
11928000 USD
us-gaap Inventory Write Down
InventoryWriteDown
400000 USD
us-gaap Inventory Write Down
InventoryWriteDown
800000 USD
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72864000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68206000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23397000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17309000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49467000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50897000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
2100000 USD
us-gaap Depreciation
Depreciation
6100000 USD
CY2018Q3 us-gaap Depreciation
Depreciation
1700000 USD
us-gaap Depreciation
Depreciation
2900000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13139000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9742000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40747000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28330000 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6024995 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22674062 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1042286 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3042201 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.94
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
160241 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
35045 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
23.41
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20478861 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M24D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
186407000 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15860131 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M18D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
181542000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.018
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.017
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
126630000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Net Income Loss
NetIncomeLoss
329981000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303268000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301999000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297700000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12185000 shares
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13930000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13047000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15500000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315453000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
312346000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
313200000 shares
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2695000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2738000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23661000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12099000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
26356000 USD
CY2018Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14837000 USD
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
50000 USD
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
49000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
44000 USD
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
79000 USD
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
94000 USD
CY2018Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
128000 USD
CY2019Q3 exel Operating And Finance Leases Liability Total
OperatingAndFinanceLeasesLiabilityTotal
26450000 USD
CY2018Q4 exel Operating And Finance Leases Liability Total
OperatingAndFinanceLeasesLiabilityTotal
14965000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
692000 USD
CY2018Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1614000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1768000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
3587000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
274000 USD
CY2018Q3 us-gaap Variable Lease Cost
VariableLeaseCost
363000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
654000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1366000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
966000 USD
CY2018Q3 us-gaap Lease Cost
LeaseCost
1977000 USD
us-gaap Lease Cost
LeaseCost
2422000 USD
us-gaap Lease Cost
LeaseCost
4953000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2100000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
745000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3625000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3731000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3852000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3959000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
17444000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33356000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5258000 USD
CY2019Q3 exel Tenant Lease Improvements Allowance
TenantLeaseImprovementsAllowance
1742000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
26356000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0420
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D

Files In Submission

Name View Source Status
0000939767-19-000190-index-headers.html Edgar Link pending
0000939767-19-000190-index.html Edgar Link pending
0000939767-19-000190.txt Edgar Link pending
0000939767-19-000190-xbrl.zip Edgar Link pending
exel-20190927.xsd Edgar Link pending
exel-20190927_cal.xml Edgar Link unprocessable
exel-20190927_def.xml Edgar Link unprocessable
exel-20190927_lab.xml Edgar Link unprocessable
exel-20190927_pre.xml Edgar Link unprocessable
exel2019093010-q.htm Edgar Link pending
exel2019093010-q_htm.xml Edgar Link completed
exel20190930exhibit101.htm Edgar Link pending
exel20190930exhibit102.htm Edgar Link pending
exel20190930exhibit103.htm Edgar Link pending
exel20190930exhibit311.htm Edgar Link pending
exel20190930exhibit312.htm Edgar Link pending
exel20190930exhibit321.htm Edgar Link pending
exellogo19q3.jpg Edgar Link pending
exhibit102image1601.jpg Edgar Link pending
exhibit102image1701a.jpg Edgar Link pending
exhibit102image1701b.jpg Edgar Link pending
exhibit102image1751a.jpg Edgar Link pending
exhibit102image1751b.jpg Edgar Link pending
exhibit102image1801a.jpg Edgar Link pending
exhibit102image1801b.jpg Edgar Link pending
exhibit102image1851a.jpg Edgar Link pending
exhibit102image1851b.jpg Edgar Link pending
exhibit102imagerent1601.jpg Edgar Link pending
exhibit102imagerent1701.jpg Edgar Link pending
exhibit102imagerent1751.jpg Edgar Link pending
exhibit102imagerent1801.jpg Edgar Link pending
exhibit102imagerent1851.jpg Edgar Link pending
exhibit102imagetma.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending